Catalent Oral Content
-
Analytical Quality By Design Using Design Of Experiments
11/21/2019
Design of Experiment (DoE) is the centerpiece of analytical Quality by Design. A DoE assay development pipeline approach delivers optimized, robust, and rugged analytical methods ready for method qualification.
-
Solutions For Challenging Compounds Using Softgel Innovation
5/5/2017
The significant interest in semi-solid systems for the potential of extended release profiles has prompted researchers to develop alternative encapsulating systems.
-
HPAPI Drug Product Development And Manufacturing Using Micronization Technology
Learn how to classify HPAPIs in early development and recommendations for safe product handling, from clinical manufacturing to commercialization.
-
Solving Delivery Challenges For Tolerogenic Vaccines
Explore the advantages offered by an orally dissolving tablet platform relating to large molecule storage, aggregation, and, in some cases, protease activity.
-
Patient-Centric Solutions To Optimize Medication Adherence
Explore how orally disintegrating tablets act as a patient-centric solution to various factors that impact treatment adherence rates across various diseases.
-
Innovative Softgel Technologies To Deliver Poorly Soluble Molecules
Learn how to expedite the development pathway for early phase compounds and how lipid based formulations provide an innovative approach to enhance bioavailability for challenging molecules.
-
Unlocking A Patient Preference For Rapid Onset In Treating Migraines
Examine the case study and learn how formulating an orally disintegrating tablet (ODT) created a convenient dosage form with a shorter Tmax for the treatment of acute migraine.